Literature DB >> 2189949

Diagnostic methods for peripheral arterial disease in the San Luis Valley Diabetes Study.

W R Hiatt1, J A Marshall, J Baxter, R Sandoval, W Hildebrandt, L R Kahn, R F Hamman.   

Abstract

Peripheral arterial disease (PAD) is a frequent complication of diabetes mellitus. In the first phase of the San Luis Valley Diabetes Study, diagnostic criteria for PAD were evaluated in 607 controls and 343 diabetics. Normal ranges, and the lowest 2.5 percentile of the distribution of ankle/arm systolic blood pressure ratios were derived from a non-diabetic subset of the population with a very low probability of PAD. From this subgroup, abnormal ankle/arm ratios were defined as less than: 0.94 at rest, 0.73 after exercise, and 0.78 after reactive hyperemia. Using these criteria, PAD was identified in 130 subjects from the study population of 950 (prevalence of 13.7%). In contrast, a history of intermittent claudication, or an absent pulse in the extremity were uncommon findings in the study population, and thus had a low sensitivity and positive predictive value for PAD diagnosed by vascular laboratory criteria. We conclude that vascular laboratory tests provide a useful, and objective means of determining the prevalence of PAD in a geographically-based population of diabetic and control subjects.

Entities:  

Mesh:

Year:  1990        PMID: 2189949     DOI: 10.1016/0895-4356(90)90164-k

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  53 in total

1.  Spinal claudication versus arterial claudication.

Authors:  M Maher; D J Hehir; P Neary; J Hinchion; J A O'Donnell
Journal:  Ir J Med Sci       Date:  1996 Apr-Jun       Impact factor: 1.568

2.  Effect of cognitive status on exercise performance and quality of life in patients with symptomatic peripheral artery disease.

Authors:  Andrew W Gardner; Shari R Waldstein; Polly S Montgomery; Yan D Zhao
Journal:  J Vasc Surg       Date:  2015-10-23       Impact factor: 4.268

3.  Peripheral arterial disease and ankle-brachial pressure index as predictors of mortality in residents of Metlika County, Slovenia.

Authors:  Blaz Mlacak; Ales Blinc; Maja Pohar; Janez Stare
Journal:  Croat Med J       Date:  2006-04       Impact factor: 1.351

4.  Association between gait characteristics and endothelial oxidative stress and inflammation in patients with symptomatic peripheral artery disease.

Authors:  Andrew W Gardner; Polly S Montgomery; Ana I Casanegra; Federico Silva-Palacios; Zoltan Ungvari; Anna Csiszar
Journal:  Age (Dordr)       Date:  2016-06-06

5.  Changes in vascular and inflammatory biomarkers after exercise rehabilitation in patients with symptomatic peripheral artery disease.

Authors:  Andrew W Gardner; Donald E Parker; Polly S Montgomery
Journal:  J Vasc Surg       Date:  2019-03-25       Impact factor: 4.268

6.  Sedentary behavior is associated with impaired biomarkers in claudicants.

Authors:  Breno Q Farah; Raphael M Ritti-Dias; Polly S Montgomery; Ana I Casanegra; Federico Silva-Palacios; Andrew W Gardner
Journal:  J Vasc Surg       Date:  2015-10-27       Impact factor: 4.268

Review 7.  The prognosis of non-critical limb ischaemia: a systematic review of population-based evidence.

Authors:  J D Hooi; H E Stoffers; J A Knottnerus; J W van Ree
Journal:  Br J Gen Pract       Date:  1999-01       Impact factor: 5.386

8.  The effect of claudication pain on temporal and spatial gait measures during self-paced ambulation.

Authors:  Andrew W Gardner; Polly S Montgomery; Raphael M Ritti-Dias; Larry Forrester
Journal:  Vasc Med       Date:  2009-09-25       Impact factor: 3.239

9.  Screening of diabetic foot in surgical inpatients: a hospital-based study in saudi arabia.

Authors:  Mohamed A Elsharawy; Khairi Hassan; Naif Alawad; Ali Kredees; Abdelmohsen Almulhim
Journal:  Int J Angiol       Date:  2012-12

Review 10.  Ankle brachial pressure index (ABPI): An update for practitioners.

Authors:  Mo Al-Qaisi; David M Nott; David H King; Sam Kaddoura
Journal:  Vasc Health Risk Manag       Date:  2009-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.